Coherus Oncology
CHRS
CHRS
115 hedge funds and large institutions have $867M invested in Coherus Oncology in 2018 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 48 increasing their positions, 25 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
12% more funds holding
Funds holding: 103 → 115 (+12)
2.9% more ownership
Funds ownership: 91.94% → 94.83% (+2.9%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
115
Holding in Top 10
1
Calls
$14.6M
Puts
$9.23M
Top Buyers
| 1 | +$11.8M | |
| 2 | +$11.3M | |
| 3 | +$10.9M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$8.84M |
| 5 |
MWNA
Marshall Wace North America
New York
|
+$8.75M |
Top Sellers
| 1 | -$8.29M | |
| 2 | -$4.14M | |
| 3 | -$4.06M | |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$2.98M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$2.68M |